Aortobifemoral bypass vs covered endovascular reconstruction of aortic bifurcation
Journal of Vascular Surgery · 2024-08 · 80 (2) · 459-465.e2
DOI: 10.1016/j.jvs.2024.03.437 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Vascular Surgery, 2024-08. Verfasst von Dana B Semaan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Allegheny Health Network, Pittsburgh, PA. Hauptthemen laut MEDLINE: Vascular Patency, Endovascular Procedures, Blood Vessel Prosthesis Implantation, Aortic Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Covered endovascular reconstruction of aortic bifurcation (CERAB) is increasingly used as a first line-treatment in patients with aortoiliac occlusive disease (AIOD). We sought to compare the outcomes of patients who underwent CERAB compared with the gold standard of aortobifemoral bypass (ABF). METHODS: The Vascular Quality Initiative was queried for patients who underwent ABF or CERAB from 2009 to 2021. Propensity scores were generated using demographics, comorbidities, Rutherford class, and urgency. The two groups were matched using 5-to-1 nearest-neighbor match. Our primary outcomes were 1-year estimates of primary patency, major adverse limb events (MALEs), MALE-free survival, reintervention-free survival, and amputation-free survival. Standard statistical methods were used. RESULTS: A total of 3944 ABF and 281 CERAB cases were identified. Of all patients with AIOD, the proportion of CERAB increased from 0% to 17.9% between 2009 and 2021. Compared with ABF, patients who underwent CERAB were more likely to be older (64.7 vs 60.2; P < .001) and more often had diabetes (40.9% vs 24.1%; P < .001) and end-stage renal disease (1.1% vs 0.3%; P = .03). In the matched analysis (229 CERAB vs 929 ABF), ABF patients had improved MALE-free survival (93.2% [±0.9%] vs 83.2% [±3%]; P < .001) and lower rates of MALE (5.2% [±0.9%] vs 14.1% [±3%]; P < .001), with comparable primary patency rates (98.3% [±0.3%] vs 96.6% [±1%]; P = .6) and amputation-free survival (99.3% [±0.3%] vs 99.4% [±0.6%]; P = .9). Patients in the CERAB group had significantly lower reintervention-free survival (62.5% [±6%] vs 92.9% [±0.9%]; P < .001). Matched analysis also revealed shorter length of stay (1 vs 7 days; P < .001), as well as lower pulmonary (1.2% vs 6.6%; P = .01), renal (1.8% vs 10%; P < .001), and cardiac (1.8% vs 12.8%; P < .001) complications among CERAB patients. CONCLUSIONS: CERAB had lower perioperative morbidity compared with ABF with a similar primary patency 1-year estimates. However, patients who underwent CERAB experienced more major adverse limb events and reinterventions. Although CERAB is an effective treatment for patients with AIOD, further studies are needed to determine the long-term outcomes of CERAB compared with the established durability of ABF and further define the role of CEARB in the treatment of AIOD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Allegheny Health Network, Pittsburgh, PA.
- MedStar Herat and Vascular Institute, Baltimore, MD.
- Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston, MA.
- Division of Vascular Surgery, UPMC, Pittsburgh, PA.
- Division of Vascular Surgery, Rutgers New Jersey Medical School, Newark, NJ.
- Division of Vascular and Endovascular Surgery, Charleston Area Medical Center, Charleston, WV. Electronic address: mohammad.eslami@vandaliahealth.org.
Zitieren
APA
Semaan, D. B., Habib, S. G., Abdul-Malak, O. M., Siracuse, J. J., Madigan, M. C., Salem, K. M., Chaer, R. A., & Eslami, M. H. (2024). Aortobifemoral bypass vs covered endovascular reconstruction of aortic bifurcation. Journal of Vascular Surgery, 80(2), 459-465.e2. https://doi.org/10.1016/j.jvs.2024.03.437
Vancouver
Semaan DB, Habib SG, Abdul-Malak OM, Siracuse JJ, Madigan MC, Salem KM, et al. Aortobifemoral bypass vs covered endovascular reconstruction of aortic bifurcation. Journal of Vascular Surgery. 2024;80(2):459-465.e2. doi:10.1016/j.jvs.2024.03.437
BibTeX
@article{Semaan2024,
author = {Semaan, Dana B and Habib, Salim G and Abdul-Malak, Othman M and Siracuse, Jeffrey J and Madigan, Michael C and Salem, Karim M and Chaer, Rabih A and Eslami, Mohammad H},
title = {Aortobifemoral bypass vs covered endovascular reconstruction of aortic bifurcation},
journal = {Journal of Vascular Surgery},
year = {2024},
volume = {80},
number = {2},
pages = {459--465.e2},
doi = {10.1016/j.jvs.2024.03.437}
}
EUVIMED